JNM (July 2018): Alpha-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 2
JNM (July 2018): Alpha-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 2

JNM (July 2018): Alpha-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 2

JNM, June 2018, Volume 59, Number 6

Member Fee: Free
Non-Member Fee: $15.00

Release Date: July 1, 2018
Expiration Date: July 30, 2021


Authors

Sophie Poty1, Lynn C. Francesconi2,3, Michael R. McDevitt1,4, Michael J. Morris5, and Jason S. Lewis1,6

1Department of Radiology and Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York;
2Department of Chemistry, Hunter College, New York, New York; 3Graduate Center of City University of New York, New York, New
York; 4Department of Radiology, Weill Cornell Medical College, New York, New York; 5Department of Medicine, Memorial Sloan
Kettering Cancer Center, New York, New York; and 6Departments of Radiology and Pharmacology, Weill Cornell Medical College,
New York, New York

 

Financial Disclosure

   

 

Name 

Role 

Disclosure 

Sophie Poty

Author

Dr. Poty is supported by the Francxois Wallace Monahan Fellowship from the JLM Benevolent Fund.

Lynn C. Francesconi

Author

No relevant financial relationships to disclose.

Michael R. McDevitt

Author

No relevant financial relationships to disclose.

Michael J. Morris

Author

No relevant financial relationships to disclose.

Jason S. Lewis

Author

Dr. Lewis is supported by the Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research and by the Center for Experimental Therapeutics of Memorial Sloan Kettering Cancer Center.

This work is supported by the Radiochemistry and Molecular Imaging Probe Core, which is supported in part by NIH/NCI Cancer Center Support Grant P30 CA008748.

Todd E. Peterson, PhD 

Chair, Publications Committee 

Johannes Czernin, MD 

Editor-In-Chief 

Heiko Schoder, MD 

Associate Editor, Continuing Education 

Arnold M. Strashun, MD 

Chair, Continuing Education Committee 

Norbert Avril, MD

JNM Reviewer 

David Groheux, MD

JNM Reviewer 

Susan Alexander 

SNMMI Staff, Publications 

Caroline Krystek 

SNMMI Staff, Education 

 No Commercial Support was received for this activity 

 

The following members of the Publications Committee have no relevant financial relationships to disclose. 

Danny A. Basso, CNMT, NCT 

Michael M. Graham, PhD, MD 

Heinrich R. Schelbert, MD, PhD 

Henry F. VanBrocklin, PhD 

Paige B. Bennett, MD 

Hossein Jadvar, MD, PhD, MPH, MBA 

Heiko Schoder, MD 

Harvey A. Ziessman, MD 

Johannes Czernin, MD 

Steven M. Larson, MD, FACNM 

Mathew L. Thakur, PhD 

Rebecca Maxey - SNMMI Staff  

Stanley J. Goldsmith, MD 

Rustain L. Morgan, MD 

Kathy S. Thomas, MHA,CNMT,PET 

 

In accordance with ACCME Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the planners and authors have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.  

The JNM editors, reviewers and SNMMI Staff have indicated that they do not have a financial interest, arrangement or affiliation with any commercial organization that may have a direct or indirect interest in the content of manuscripts submitted to JNM. 

 

Target Audience

This article contains information of value to nuclear medicine pharmacists and technologists.


Objectives 

At the completion of this activity, the participant should be able to:

1. Match alpha-emitters to potential vectors or targets of interest.
2. Highlight the potential of alpha-emitters in preclinical work.
3. Identify the current clinical uses of alpha-emitters and the importance of clinical trial design for broader application of alpha-therapy.


Continuing Education Credit Information

ACPE (Pharmacists)
The Society for Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE. Total available credit for pharmacists is 1.0 hours or 0.10 CEUs. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation. You will have no more than 3 attempts to successfully complete the post-test. ACPE UPN:
0210-0000-18-103-H04-P.

VOICE (Technologists)
The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this journal article for a maximum of 1.0 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A+ credit. In order to receive CE credit, you must first complete the activity content. When completed, take the post-test assessment.  You must obtain a score of 80% to receive the CE credit.  You will have no more than 3 attempts to successfully complete the post-test. California Scope: 1.0 Non-Imaging (NI).


Minimum system requirements

Supported Operating Systems: Windows (8/7/Vista/XP) or Mac OS X

Supported Internet Browsers: Windows OS Users:
- Microsoft Internet Explorer (version 8 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)

Supported Internet Browsers: Mac OS X Users:
- Apple Safari (version 4 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)

Internet Browser Settings:
- Pop-Up Blocker should be disabled
- Java Script should be enabled
- Java should be enabled
- Cookies should be enabled

Plug-ins:
- Adobe Flash Player (http://get.adobe.com/flashplayer/)
- Adobe Acrobat Reader (http://get.adobe.com/reader/)

Hardware Requirements:
- Computer:  1 GHz with 500 MB RAM or better
- Internet Connection:  A broadband connection (DSL, Cable, etc.)
- Sound:  Speakers or headset to hear audio
- Display:  A display screen area of 800 x 600 pixels or higher

Policy on Privacy and Confidentiality: http://www.snmmi.org/index.cfm?PageID=926

For questions please contact the Education Department at Education@snmmi.org 703-708-9000.

© 2018 SNMMI. All rights reserved.   


Type:     Internet Activity (Enduring Material)
215 Registered Users